NEXGEL, Inc.

NasdaqCM NXGL

NEXGEL, Inc. Market Capitalization on January 14, 2025: USD 23.44 M

NEXGEL, Inc. Market Capitalization is USD 23.44 M on January 14, 2025, a 60.51% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

NEXGEL, Inc. 52-week high Market Capitalization is USD 33.48 M on December 16, 2024, which is 42.85% above the current Market Capitalization.
NEXGEL, Inc. 52-week low Market Capitalization is USD 11.81 M on February 21, 2024, which is -49.60% below the current Market Capitalization.
NEXGEL, Inc. average Market Capitalization for the last 52 weeks is USD 17.10 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqCM: NXGL

NEXGEL, Inc.

CEO	Mr. Adam R. Levy
IPO Date	Dec. 22, 2021
Location	United States
Headquarters	2150 Cabot Boulevard West
Employees	19
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials Cosmetics

Description

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Key trends

Past 5 years